Background: Night shift work has been associated with higher risks of breast and endometrial cancer, but few studies have evaluated associations with other reproductive cancers.
Introduction
Night shift work has been associated with increased risks of multiple cancer types (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) , including hormonally sensitive cancers such as breast (1-7) and endometrial (8) cancers, prompting the International Agency for Research on Cancer to classify night shift work as a probable carcinogen (13) . Night shift work may be linked to cancer risk by the diminished ability of the pineal gland to produce melatonin among those exposed to light at night (14) . There are likely several anticancer mechanisms for melatonin (reviewed in ref. 15 ) including modulation of estradiol levels and aromatase activity and downregulation of ERa (estrogen receptor) expression in mammary tumors.
Animal and experimental studies suggest a chemoprotective role of melatonin specifically in ovarian carcinogenesis. Treatment of ovarian cancer cell lines with melatonin resulted in growth inhibition (16) . Furthermore, in turkey breeder hens with ovarian adenocarcinomas, short day length (i.e., short exposure to sunlight) was associated with tumor regression (17) ; when the same hens were exposed to longer days, the tumors regrew. Treatment with melatonin slowed tumor growth among the hens exposed to a long day length. In healthy volunteer women, treatment with melatonin in combination with the synthetic progestin norethisterone resulted in suppression of the pituitary-ovarian axis and inhibition of ovarian function and ovulation (18) . Despite this suggestive evidence, few studies have examined the association between exposures that disrupt melatonin production such as night shift work and risk of ovarian cancer. In the Nurses' Health Study (NHS) and Nurses' Health Study II (NHSII), we prospectively examined potential associations between duration of rotating night shift work and risk of epithelial ovarian cancer.
Methods
The NHS cohort was established in 1976 among 121,700 U.S. female registered nurses, ages 30 to 55 years and NHSII was established in 1989 among 116,430 female registered nurses, ages 25 to 42 years. All women completed an initial questionnaire about their lifestyle factors, health behaviors, and medical history, and, since baseline, have been followed biennially by questionnaire to update exposure status and disease diagnoses (19, 20) .
Ascertainment of night shift working status
In 1988, NHS participants were asked how many total years they had worked rotating night shifts at least 3 nights per month in addition to day or evening shifts. Duration of rotating night shift work was ascertained in the following prespecified categories: never, 1-2, 3-5, 6-9, 10-14, 15-19, 20- 
Documentation of ovarian cancer cases and deaths
We collected information about new ovarian cancer diagnoses on each questionnaire. For all reported cases and deaths due to ovarian cancer identified by family members, the National Death Index, or the U.S. Postal Service, we obtained medical records pertaining to the ovarian cancer diagnosis. A gynecologic pathologist blinded to exposure status reviewed the medical records to confirm the diagnosis, as well as stage, histology, and invasiveness. In a subset of 215 ovarian cancer cases, concordance between the medical records and the pathologist's review was 98% for invasiveness and 83% for histologic type (21) .
Statistical analysis
The We used Cox proportional hazards regression, with age in months and 2-year questionnaire cycle as the time scale, to estimate the HRs and 95% CIs of ovarian cancer for each shift work duration category, compared with those who never worked rotating night shifts, adjusting for known and suspected ovarian cancer risk factors (see Tables for detail) . Tests for trend were conducted by treating the shift work duration categories as an ordinal variable and calculating Wald's statistic.
Data analyses were conducted separately for both cohorts and then pooled using a random effects model to test for heterogeneity (22) . To assess whether results varied by menopausal status (pre-vs. postmenopausal), age (<55 vs., 55þ years), postmenopausal hormone (PMH) use (never vs. ever; postmenopausal only), menstrual regularity (no irregularity vs. any irregularity), body mass index [(BMI) <25 vs. 25þ], or infertility, we included multiplicative interaction terms in multivariate models and tested their significance using Wald's statistic.
We conducted several sensitivity analyses. First, because duration of shift work was only collected once in NHS, we analyzed NHSII using only the reported baseline shift work duration, in addition to our primary analyses in which we updated shift work information. In addition, because there were so few cases in the higher duration categories, we analyzed the data in categories of none, 1-5, 6-14, and 15þ years. We also conducted an analysis censoring all women who did not respond to the shift work questions after baseline (in NHSII). Finally, we conducted both a 2-and 4-year lag analysis to account for potential healthy worker effects.
Results
At the midpoint of follow-up, 41.0% of the NHS participants and 32.2% of NHSII participants reported never having worked rotating night shifts. Women who reported never working night shifts generally were similar to women who reported night shift work, except that those who had worked rotating night shifts for at least 20 years were older, had a higher BMI, and were more likely to smoke (Table 1) .
Combining both cohorts, there was no association between duration of rotating night shift work and risk of ovarian cancer (e.g., 15-19 years, HR: 1.28; 95% CI: 0.84-1.94; 20þ years, HR: 0.80; 95% CI: 0.51-1.23; P trend ¼ 0.74), compared with women without any night work, and results were similar across cohorts (Table 2) . Results did not differ when duration categories were collapsed, when a lag of 2 or 4 years was employed between exposure and ovarian cancer diagnosis, when only baseline NHSII duration was used, or when missing NHSII updated shift work duration values were censored (data not shown). The association between duration of rotating night shift work and ovarian cancer did not vary by category of age, menopausal status, PMH use, BMI, oral contraceptive use, menstrual irregularity, or infertility.
Discussion
In this large, prospective study of rotating night shift work and risk of ovarian cancer, we observed no association between increasing duration of night shift work and risk. Few previous studies have examined potential associations between shift work and ovarian cancer. In a Norwegian study, no association with ovarian cancer incidence was observed for radio and telegraph operators (standardized incidence ratio: 0.8; 95% CI: 0.3-1.6; ref. 5), many of whom worked night shifts. However, this result was based on only 7 cases. Karasek and colleagues compared serum circadian melatonin profiles between women with genital tract cancers (including ovarian, endometrial, and cervical cancers) with normal volunteers (23) . They reported no differences between melatonin profiles of the ovarian cancer patients compared with the normal controls, but their sample size was limited, and melatonin was measured after ovarian cancer diagnosis.
This study has several potential limitations. First, duration of rotating night shift work was only assessed once in NHS (in 1988). It is possible that the true duration of shift work was underestimated for NHS participants. However, in 1996, only 3% of nurses reported any shift work in the past 6 months, indicating that the extent of the misclassification of duration is limited. Also, duration of shift work was only updated every 4 years in NHSII; however, sensitivity analyses using only baseline shift work duration in NHSII showed similar results, suggesting that the effects of potential misclassification were minimal. Nevertheless, the possibility remains that a small proportion of nurses may have been misclassified as to their true duration of rotating night shift work.
Second, rotating night shift work was assessed through self-report and was not confirmed with personnel or hospital records. However, women in this cohort have been shown to accurately report their exposures to many lifestyle and occupational exposures (e.g., refs. 24, 25). Third, we did not collect data on permanent or infrequent rotating (<3 nights per month) night shift work. Although the disruption of melatonin production likely is less severe from these exposures, we cannot rule out the possibility that the observed lack of association in our study could be due to misclassification among a subset of women with different forms of night shift work. However, as breast, colorectal, and endometrial cancers were associated with rotating night shift work in these cohorts (3, 4, 8, 9) , the likely degree of misclassification is low.
The strengths of this analysis include the large number of ovarian cancer cases and prospective data collection. Because women were asked about their rotating shift work exposure prior to the diagnosis of ovarian cancer, the likelihood of recall bias is low. Furthermore, we have collected detailed information on many of the potential confounders of the association between rotating night shift work and ovarian cancer risk, such as reproductive history and hormonal therapy, thus reducing the likelihood of uncontrolled confounding in our analysis. In NOTE: Values are means (SD) or percentages and are standardized to the age distribution of the study population. All factors except age and age at menarche were age standardized in 5-year intervals for each cohort. conclusion, increasing duration of rotating night shift work was not associated with ovarian cancer risk in the NHS and NHSII cohorts. However, further exploration of the association between melatonin and risk of ovarian cancer is warranted.
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